Honghe Fujie Lotion for the Treatment of Bacterial Vaginosis
NCT03446443 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2019-02-15
Summary
This is a Randomized, Positive -Controlled, Multi-center Trial enrolling 240 subjects with Bacterial Vaginosis who will be randomized at a ratio of 1:1 to receive active Honghe Fujie lotion or Metronidazole Suppositories. The primary objective is to assess the safety and tolerability of Honghe Fujie lotion compared to Metronidazole Suppositories.
Conditions
- Bacterial Vaginitis
Interventions
- DRUG
-
Honghe Fujie lotion
Before application,wash the vaginal area with water and dry it. Take10ml Hong He Fujie into dilution bottles,added to 100ml with warm boiled water, using diluted lotion for the rinse of vulva and vagina, twice daily for 7days.
- DRUG
-
Metronidazole Suppositories
Before bedtime,wash the vaginal area and put 0.5g Metronidazole Suppositories into posterior vaginal fornix,once daily for 7days.
Sponsors & Collaborators
-
Peking University First Hospital
collaborator OTHER -
Beijing Compete Pharmaceutical Co., Ltd.
collaborator UNKNOWN -
Shandong Buchang Pharmaceutical Co., Ltd.
collaborator UNKNOWN -
Dongfang Hospital Beijing University of Chinese Medicine
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-26
- Primary Completion
- 2019-07-31
- Completion
- 2020-02-28
Countries
- China
Study Locations
More Related Trials
-
Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV)
NCT03769688 ·Status: WITHDRAWN ·Phase: PHASE1
-
TOL-463 Phase 2 Study for Vaginitis
NCT02866227 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection
NCT06450990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis
NCT04489290 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis
NCT02709005 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women
NCT01230814 ·Status: COMPLETED ·Phase: PHASE2
-
Postbiotic as Adjunct Treatment for Vaginal Candidiasis
NCT06474247 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis
NCT02365389 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Pilot Study to Evaluate the Efficacy and Safety of Lactobacillus Species Suppositories on Vaginal Health and pH
NCT05060029 ·Status: UNKNOWN ·Phase: PHASE4
-
Vaginal Hygiene Wash as Adjunct Treatment in Bacterial Vaginosis
NCT04846361 ·Status: UNKNOWN ·Phase: NA
-
Safety and Tolerability of Metronidazole Gel 1.3%
NCT02392026 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis
NCT03091777 ·Status: COMPLETED ·Phase: PHASE3
-
DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)
NCT04370548 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis
NCT01020396 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Suppression Of Bacterial Vaginosis (BV) [SUBVert]
NCT03930745 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis
NCT06835361 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A First-in-human Safety Trial of BNT331 Administered as Single Ascending Doses in Healthy Women and as Multiple Ascending Doses in Women Diagnosed With Bacterial Vaginosis
NCT06469164 ·Status: COMPLETED ·Phase: PHASE1
-
Intravaginal Treatment of Disturbances of Vaginal Flora Among HIV Infected and Uninfected Women in Malawi
NCT00140764 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of a Vaginal Gel for the Treatment and Prevention of Vaginal Infections
NCT07234786 ·Status: RECRUITING ·Phase: NA
-
Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology
NCT02527941 ·Status: COMPLETED ·Phase: PHASE1
-
First in Human Study in Healthy Volunteers of Antimicrobial Peptide PL-18 Vaginal Suppositories
NCT05340790 ·Status: RECRUITING ·Phase: PHASE1
-
GoldenCareTM for the Treatment of Bacterial Vaginosis
NCT01762670 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis
NCT02185456 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Clinical Protocol CERN Feasibility Study
NCT06933420 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Natamycin and Lactulose Vaginal Suppositories in Treatment of Vulvovaginal Candidiasis
NCT06411314 ·Status: COMPLETED ·Phase: PHASE3